Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.. |
Info | Profile |
---|---|
Name | Darya-Varia Laboratoria Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 12/31/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
Blue Sphere Singapore PT. Ltd | 92.12 | 92.12 |
Public < 5% | 7.88 | 7.88 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 92.12 | 92.12 |
Retail | 7.88 | 7.88 |
Individual | 0.0 | 0.0 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|---|---|
Consumer Health Products | 50.9% | 55.2% |
Prescription Drugs | 37.5% | 33.3% |
Export & Toll | 10.2% | 11.5% |
Services | 1.4% | 0.0% |
Others | 0.0% | 0.0% |
Revenue Region | 2023 | 2022 |
---|---|---|
Indonesia | 90.8% | 89.4% |
International | 9.2% | 10.6% |
Others | 0.0% | 0.0% |
Year | DPS | Yield [%] |
---|---|---|
2024 | 108.0 | 6.5 |
2023 | 121.0 | 7.3 |
Timeframe | Performance |
---|---|
1W % | 1.5 |
1Mo % | 15.5 |
3Mo % | -1.5 |
1Yr % | 15.8 |
Pivot | Points |
---|---|
R2 | 1790 |
R1 | 1720 |
S1 | 1550 |
S2 | 1450 |
Link download Laporan Keuangan emiten
Stock | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
DVLA | 11.80 | 1.72 T | 2.07 T | 2.09 T | 243 B | 156 B |
KLBF | 21.78 | 58.13 T | 58.24 T | 32,628 B | 5,069 B | 3,241 B |
SIDO | 13.45 | 17.40 T | 16.99 T | 3,919 B | 1,577 B | 1,171 B |
TSPC | 7.93 | 11.95 T | 10.82 T | 13,655 B | 2,114 B | 1,448 B |
SOHO | 18.53 | 8.25 T | 10.52 T | 10,058 B | 618 B | 463 B |
KAEF | -4.88 | 2.39 T | 12.98 T | 10,486 B | -9 B | -562 B |